Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol Once-Daily in Knee Osteoarthritis
NCT00852917Phase 3Completed
- Sponsor
- Labopharm Inc.
- Start
- Jan 2003
- Primary completion
- Aug 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of tramadol in osteoarthritis (OA) (4 arms), sponsored by Labopharm Inc. Primary endpoints: Patient Global Rating of Pain for the Study Period at 12 weeks, Percentage Difference Between WOMAC Pain Subscale Score From Baseline to the End of the Study at 12 weeks and 1 more. Started Jan 2003; status: completed.
02
Drugs
tramadol
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00852917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00852917.